Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.
| Condition |
|---|
|
Type 1 Diabetes Type 2 Diabetes |
| Study Type: | Observational [Patient Registry] |
| Study Design: | Observational Model: Case-Only |
| Target Follow-Up Duration: | 1 Month |
| Official Title: | Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel |
- Prevalence rates of Diabetes [ Time Frame: Up to 100 years ] [ Designated as safety issue: No ]
- Rates of performance of eye examinations,blood and urine tests [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
- Number and types of Drugs purchased [ Time Frame: 100 years ] [ Designated as safety issue: No ]
- Number of visits to physician offices [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 126000 |
| Study Start Date: | January 1998 |
| Estimated Primary Completion Date: | December 2100 (Final data collection date for primary outcome measure) |
The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.
The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Diabetes patients.
Inclusion Criteria:
Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose >125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.
Contacts and Locations| Israel | |
| Maccabi Healthcare Services | |
| Tel Aviv, Israel, 68125 | |
| Study Director: | Gabriel Chodick, PHD | Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S |
More Information
Additional Information:
Publications:
| Responsible Party: | Maccabi Healthcare Services, Israel |
| ClinicalTrials.gov Identifier: | NCT01779115 History of Changes |
| Other Study ID Numbers: | MACCVREGDIAB |
| Study First Received: | January 28, 2013 |
| Last Updated: | January 30, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Maccabi Healthcare Services, Israel:
|
Registry,Diabetes,Health Maintenance Organization |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013